Search Results - "González Monte, E."

Everolimus-Based Immunosuppression Therapy for BK Virus Nephropathy by Polanco, N, González Monte, E, Folgueira, M.D, Morales, E, Gutiérrez Martínez, E, Bengoa, I, Hernández, A, Morales, J.M, Praga, M, Andrés, A

“…Abstract Background Mammalian target of rapamycin inhibitors (mTOR-i) have been proposed as possible immunosuppressants of choice in BK virus nephropathy (BKN)…”
Get full text

Results of Kidney Transplantation From Deceased Donors With Acute Kidney Injury by Molina, M, Apaza, J, González Monte, E, Gutiérrez Martínez, E, Sevillano, A.M, Marín, J.P, Polanco, N, Hernández, A, Praga, M, Andrés, A

“…Abstract Background Different strategies have been initiated to shorten the waiting list time to receive a kidney transplant. Donors with acute kidney injury…”
Get full text

Dual Kidney Transplantation Involving Organs From Expanded Criteria Donors: A Review of Our Series and an Update on Current Indications by Medina-Polo, J, Pamplona-Casamayor, M, Miranda-Utrera, N, González-Monte, E, Passas-Martínez, J.B, Andrés Belmonte, A

“…Abstract Background Our purpose was to review our kidney transplantation program based on the use of expanded criteria donors, and to determine current…”
Get full text

Impact of Left Ventricular Dysfunction on Renal Transplant Survival: Study of Paired Kidneys From the Same Donor by González Monte, E, Mora, M.T, Polanco, N, Morales, E, Gutiérrez, E, Molina, M, Sevillano, Á, Hernández, E, Praga, M, Andrés, A

“…Abstract Introduction A significant number of patients with chronic kidney disease (CKD) have cardiac abnormalities, and left ventricular systolic dysfunction…”
Get full text

Addition of Spironolactone to Dual Blockade of Renin Angiotensin System Dramatically Reduces Severe Proteinuria in Renal Transplant Patients: An Uncontrolled Pilot Study at 6 Months by González Monte, E, Andrés, A, Polanco, N, Toribio, M.J, Santana, R, Gutiérrez Martínez, E, González, J, Ramírez, E, Hernández, A, Morales, E, Praga, M, Morales, J.M

“…Abstract Experimental and clinical data strongly suggest that aldosterone may contribute to proteinuria and progressive renal disease. In fact, an aldosterone…”
Get full text

Results of a Living Donor Kidney Promotion Program by González Monte, E, Delgado, I, Polanco, N, Hernández, E, Dipalma, T, Hernández, A, Castillo, M, Morales, E, Praga, M, Morales, J.M, Andrés, A

“…Abstract Background Living kidney donor transplantation, a treatment option for end-stage kidney failure, may achieve better results than cadaveric donor…”
Get full text

1012 Double kidney transplantation with organs from expanded criteria donors: Review of our series and an update of current indications by Medina-Polo, J, Pamplona-Casamayor, M, Miranda-Utrera, N, González-Monte, E, Ospina-Galeano, I.A, Guerrero-Ramos, F, Andrés-Belmonte, A, Díaz-González, R

Get full text

EXCELLENT SHORT-TERM OUTCOMES IN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC ALLOGRAFT DYSFUNCTION WITH NEGATIVE/LOW PROTEINURIA SWITCHING TO EVEROLIMUS: 2558 by Monte, González E., Polanco, N. I., Hernández, A., Caballero, J. I., Andres, A., Morales, J. M.

Get full text

Anti-CD20 and mTOR inhibitors: Can we change the prognosis of post-transplant lymphoproliferative disorder? by Guerrero Ramos, F., Cavero Escribano, T., Pamplona Casamayor, M., Rodriguez Antolín, A., Duarte Ojeda, J., Tejido Sánchez, Á., Villacampa Aubá, F., Medina Polo, J., González Monte, E., Passas Martínez, J., De La Rosa Kehrmann, F.

Get full text

533 - Anti-CD20 and mTOR inhibitors: Can we change the prognosis of post-transplant lymphoproliferative disorder? by Guerrero Ramos, F., Cavero Escribano, T., Pamplona Casamayor, M., Rodriguez Antolín, A., Duarte Ojeda, J., Tejido Sánchez, Á., Villacampa Aubá, F., Medina Polo, J., González Monte, E., Passas Martínez, J., De La Rosa Kehrmann, F.

Get full text

Está disminuyendo la incidencia de la hipertensión arterial maligna o está cambiando su presentación clínica? by Morales Ruiz, E., Ortiz Librero, M., González Monte, E.

“…Numerosos estudios clínicos describen que la incidencia de la hipertensión arterial maligna (HTAM) va disminuyendo. La hipertensión arterial maligna es una…”
Get full text